• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login

Novo Nordisk Canada Inc.

Member Profile

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 42,700 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.ca, Twitter, or YouTube.

Sector
Biotechnology, Global Pharmaceutical Corporations, Therapeutics
Area of Expertise
  • Bioinformatics
  • Bioprocessing
  • Bioproducts
  • Cardiovascular Disease
  • Cellular Medicine
  • Disease Prevention
  • Distributor
  • Drug Delivery
  • Drug Discovery
  • Infectious Diseases
  • Inflammatory Diseases
  • Manufacturer
  • Metabolic Diseases
  • Oncology
  • Pathology Services
  • Pediatrics
  • Product Development
  • Therapeutics
  • Women’s Health
Company Stage Commercial Stage, Public Company
Stock Ticker NOVO-B - CPH

Member Profile

Biotechnology, Global Pharmaceutical Corporations, Therapeutics

Novo Nordisk Canada Inc.

Bronze Sponsor

Nova Nordisk Canada logo
  • Website www.novonordisk.ca/
  • Phone +1 (800) 465 4334
  • Address
    101-2476 Argentia Road
    Mississauga, ON
    L5N 6M1
  • Leadership Contact
    Béatrice Clerc, President, Canada
    Follow us:
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • News
  • Jobs

October 26, 2022

Health Canada Approves REBINYN® (Coagulation Factor IX (Recombinant), pegylated) for the Treatment of Routine Prophylaxis to Prevent or Reduce Frequency of Bleeding Episodes in Children With Hemophilia B

December 12, 2021

Novo Nordisk Invests More than DKK 17 bn in Expansion of the Manufacturing Facilities in Kalundborg, Denmark

November 19, 2021

Novo Nordisk to Acquire Dicerna Pharmaceuticals Including the RNAi Research Technology Platform

November 19, 2021

A New Initiative for Diabetes Prevention and Innovative Care: Chum Launches the Centre d’Expertise en Diabète an Initiative Supported by a 5M$ Donation from Novo Nordisk

No current content.

  • Twitter
  • Linkedin
Tweets by Novo Nordisk Canada Inc.
Connect with us LinkedIn

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us